A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy

Objective:Reducing viral load, highly active antiretroviral therapy has the potential to limit onwards transmission of HIV-1 and thus help contain epidemic spread. However, increases in risk behaviour and resurgent epidemics have been widely reported post-highly active antiretroviral therapy. The aim of this study was to quantify the impact that highly active antiretroviral therapy had on the epidemic. Design:We focus on the HIV-1 epidemic among men who have sex with men in the Netherlands, which has been well documented over the past 20 years within several long-standing national surveillance programs. Methods:We used a mathematical model including highly active antiretroviral therapy use and estimated the changes in risk behaviour and diagnosis rate needed to explain annual data on HIV and AIDS diagnoses. Results:We show that the reproduction number R(t), a measure of the state of the epidemic, declined early on from initial values above two and was maintained below one from 1985 to 2000. Since 1996, when highly active antiretroviral therapy became widely used, the risk behaviour rate has increased 66%, resulting in an increase of R(t) to 1.04 in the latest period 2000–2004 (95% confidence interval 0.98–1.09) near or just above the threshold for a self-sustaining epidemic. Hypothetical scenario analysis shows that the epidemiological benefits of highly active antiretroviral therapy and earlier diagnosis on incidence have been entirely offset by increases in the risk behaviour rate. Conclusion:We provide the first detailed quantitative analysis of the HIV epidemic in a well defined population and find a resurgent epidemic in the era of highly active antiretroviral therapy, most likely predominantly caused by increasing sexual risk behaviour.

[1]  M. Prins,et al.  Condom Use Rather Than Serosorting Explains Differences in HIV Incidence Among Men Who Have Sex With Men , 2007, Journal of acquired immune deficiency syndromes.

[2]  Neil M Ferguson,et al.  The epidemiological impact of antiretroviral use predicted by mathematical models: a review , 2005, Emerging themes in epidemiology.

[3]  Mark A van de Wiel,et al.  Mortality and progression to AIDS after starting highly active antiretroviral therapy , 2003, AIDS.

[4]  M. Hirsch,et al.  Prevalence and predictive value of intermittent viremia with combination hiv therapy. , 2001, JAMA.

[5]  Phalguni Gupta,et al.  Adherence to Antiretroviral Therapy and Persistence of HIV RNA in Semen , 2003, Journal of acquired immune deficiency syndromes.

[6]  S. Vermund,et al.  Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. , 2001, AIDS research and human retroviruses.

[7]  I. Stolte,et al.  Increase of sexually transmitted infections, but not HIV, among young homosexual men in Amsterdam: are STIs still reliable markers for HIV transmission? , 2005, Sexually Transmitted Infections.

[8]  Steven Gibson,et al.  Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. , 2002, American journal of public health.

[9]  Mirjam Kretzschmar,et al.  The contribution of steady and casual partnerships to the incidence of HIV infection among homosexual men in Amsterdam , 2003, AIDS.

[10]  H. Gershengorn,et al.  Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? , 2002, The Lancet. Infectious diseases.

[11]  O. Laeyendecker,et al.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. , 2005, The Journal of infectious diseases.

[12]  M. Dijkgraaf,et al.  AIDS scenarios for The Netherlands; the economic impact on hospitals. , 1995, Health policy.

[13]  M. Law,et al.  Modeling Trends in HIV Incidence Among Homosexual Men in Australia 1995–2006 , 2004, Journal of acquired immune deficiency syndromes.

[14]  E. De Clercq,et al.  Managing resistance to anti-HIV drugs: an important consideration for effective disease management. , 1999, Drugs.

[15]  William C Miller,et al.  Detection of acute infections during HIV testing in North Carolina. , 2005, The New England journal of medicine.

[16]  S. Kippax,et al.  Modelling the effect of combination antiretroviral treatments on HIV incidence , 2001, AIDS.

[17]  M. S. Sánchez,et al.  HIV Drug-resistant Strains as Epidemiologic Sentinels , 2006, Emerging infectious diseases.

[18]  P. Kaye Infectious diseases of humans: Dynamics and control , 1993 .

[19]  P. Vernazza,et al.  Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  HOMAS,et al.  VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 VIRAL LOAD AND HETEROSEXUAL TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 , 2000 .

[21]  S. Hammer,et al.  A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team. , 1996, The New England journal of medicine.

[22]  C. Fraser Estimating Individual and Household Reproduction Numbers in an Emerging Epidemic , 2007, PloS one.

[23]  J. Dilley,et al.  Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: a suggestion of HIV serosorting? , 2006, Sexually Transmitted Infections.

[24]  Prabhat Jha,et al.  Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission. , 2002, Bulletin of the World Health Organization.

[25]  I. Stolte,et al.  Low HIV-testing rates among younger high-risk homosexual men in Amsterdam , 2007, Sexually Transmitted Infections.

[26]  Gary Marks,et al.  Meta-Analysis of High-Risk Sexual Behavior in Persons Aware and Unaware They are Infected With HIV in the United States: Implications for HIV Prevention Programs , 2005, Journal of acquired immune deficiency syndromes.

[27]  R. Geskus,et al.  Declining AIDS Mortality in Amsterdam: Contributions of Declining HIV Incidence and Effective Therapy , 2004, Epidemiology.

[28]  J. Goudsmit,et al.  Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands. , 1987, American journal of epidemiology.

[29]  B. Berkhout,et al.  Declining trend in transmission of drug-resistant HIV-1 in Amsterdam , 2004, AIDS.

[30]  Ronald B Geskus,et al.  HIV incidence and HIV testing behavior in men who have sex with men: using three incidence sources, The Netherlands, 1984–2005 , 2007, AIDS.

[31]  R. Geskus,et al.  Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study , 2004, AIDS.

[32]  V. Cejka,et al.  [Kaposi's sarcoma and fatal opportunistic infections in a homosexual man with immunodeficiency]. , 1983, Nederlands tijdschrift voor geneeskunde.

[33]  M. Boerlijst,et al.  Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains , 2001, AIDS.

[34]  H. Gershengorn,et al.  A tale of two futures: HIV and antiretroviral therapy in San Francisco. , 2000, Science.

[35]  G. Garnett,et al.  Is HIV out of control in the UK? An example of analysing patterns of HIV spreading using incidence-to-prevalence ratios , 2006, AIDS.

[36]  L. Kingsley,et al.  High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors , 1997, Journal of virology.